Hollsteen
← Jabil

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $161M · 10-Q 0001193125-16-422561 filed Jan 6, 2016D&A · Q2 FY2016: $168M · derived · 10-Q 0001193125-17-111778 filed Apr 5, 2017D&A · Q3 FY2016: $184M · derived · 10-Q 0001193125-17-219901 filed Jun 30, 2017D&A · Q4 FY2016: $184M · derived · 10-K 0001193125-17-313834 filed Oct 19, 2017D&A · Q1 FY2017: $189M · 10-Q 0001193125-17-005745 filed Jan 9, 2017D&A · Q2 FY2017: $191M · derived · 10-Q 0001193125-18-108777 filed Apr 5, 2018D&A · Q3 FY2017: $190M · derived · 10-Q 0001193125-18-207639 filed Jun 28, 2018D&A · Q4 FY2017: $190M · derived · 10-K 0001193125-18-303041 filed Oct 19, 2018D&A · Q1 FY2018: $195M · 10-Q 0001193125-18-002956 filed Jan 4, 2018D&A · Q2 FY2018: $188M · derived · 10-Q 0001193125-19-097892 filed Apr 4, 2019D&A · Q3 FY2018: $201M · derived · 10-Q 0001193125-19-186025 filed Jun 28, 2019D&A · Q4 FY2018: $190M · derived · 10-K 0001193125-19-271646 filed Oct 22, 2019D&A · Q1 FY2019: $189M · 10-Q 0001193125-19-005404 filed Jan 9, 2019D&A · Q2 FY2019: $193M · derived · 10-Q 0001193125-20-094625 filed Apr 1, 2020D&A · Q3 FY2019: $193M · derived · 10-Q 0001193125-20-183269 filed Jun 29, 2020D&A · Q4 FY2019: $197M · derived · 10-K 0001193125-20-274411 filed Oct 22, 2020D&A · Q1 FY2020: $203M · 10-Q 0001193125-20-001434 filed Jan 3, 2020D&A · Q2 FY2020: $199M · derived · 10-Q 0001193125-21-104662 filed Apr 2, 2021D&A · Q3 FY2020: $198M · derived · 10-Q 0001193125-21-207682 filed Jul 2, 2021D&A · Q4 FY2020: $194M · derived · 10-K 0001193125-21-305429 filed Oct 22, 2021D&A · Q1 FY2021: $249M · 10-Q 0001193125-22-004029 filed Jan 7, 2022D&A · Q2 FY2021: $244M · derived · 10-Q 0001193125-22-092806 filed Apr 1, 2022D&A · Q3 FY2021: $237M · derived · 10-Q 0001193125-22-186715 filed Jul 1, 2022D&A · Q4 FY2021: $146M · derived · 10-K 0001193125-22-268383 filed Oct 25, 2022D&A · Q1 FY2022: $269M · 10-Q 0001193125-22-004029 filed Jan 7, 2022D&A · Q2 FY2022: $255M · derived · 10-Q 0001193125-23-091542 filed Apr 5, 2023D&A · Q3 FY2022: $244M · derived · 10-Q 0001193125-23-179422 filed Jun 30, 2023D&A · Q4 FY2022: $157M · derived · 10-K 0001193125-23-259599 filed Oct 20, 2023D&A · Q1 FY2023: $263M · 10-Q 0001193125-23-003543 filed Jan 6, 2023D&A · Q2 FY2023: $251M · derived · 10-Q 0001628280-24-014951 filed Apr 5, 2024D&A · Q3 FY2023: $238M · derived · 10-Q 0001628280-24-031429 filed Jul 9, 2024D&A · Q4 FY2023: $172M · derived · 10-K 0001628280-24-043960 filed Oct 28, 2024D&A · Q1 FY2024: $206M · 10-Q 0001193125-24-004852 filed Jan 9, 2024D&A · Q2 FY2024: $150M · derived · 10-Q 0001628280-25-017004 filed Apr 8, 2025D&A · Q3 FY2024: $201M · derived · 10-Q 0001628280-25-033410 filed Jun 30, 2025D&A · Q4 FY2024: $139M · derived · 10-K 0001628280-25-045293 filed Oct 17, 2025D&A · Q1 FY2025: $182M · 10-Q 0001628280-25-001058 filed Jan 10, 2025D&A · Q2 FY2025: $191M · derived · 10-Q 0001628280-26-024148 filed Apr 8, 2026D&A · Q3 FY2025: $249M · derived · 10-Q 0001628280-26-046138 filed Jun 30, 2026D&A · Q4 FY2025: $52.0M · derived · 10-K 0001628280-25-045293 filed Oct 17, 2025D&A · Q1 FY2026: $267M · 10-Q 0001628280-26-001450 filed Jan 9, 2026D&A · Q2 FY2026: $182M · derived · 10-Q 0001628280-26-024148 filed Apr 8, 2026D&A · Q3 FY2026: $196M · derived · 10-Q 0001628280-26-046138 filed Jun 30, 2026184a196a161269Q1 FY2016Q3 FY2026
$MD&A · Q1 FY2016: $161M · 10-Q 0001193125-16-422561 filed Jan 6, 2016D&A · Q2 FY2016: $168M · derived · 10-Q 0001193125-17-111778 filed Apr 5, 2017D&A · Q3 FY2016: $184M · derived · 10-Q 0001193125-17-219901 filed Jun 30, 2017D&A · Q4 FY2016: $184M · derived · 10-K 0001193125-17-313834 filed Oct 19, 2017D&A · Q1 FY2017: $189M · 10-Q 0001193125-17-005745 filed Jan 9, 2017D&A · Q2 FY2017: $191M · derived · 10-Q 0001193125-18-108777 filed Apr 5, 2018D&A · Q3 FY2017: $190M · derived · 10-Q 0001193125-18-207639 filed Jun 28, 2018D&A · Q4 FY2017: $190M · derived · 10-K 0001193125-18-303041 filed Oct 19, 2018184a190a161191aQ1 FY2016Q4 FY2017Q4 FY2016
Q4 FY2016
184a$M
derived
All values (43)
PeriodValue ($M)Status
Q3 FY2026196derived
Q2 FY2026182derived
Q1 FY2026267reported
Q4 FY202552derived
Q3 FY2025249derived
Q2 FY2025191derived
Q1 FY2025182reported
Q4 FY2024139derived
Q3 FY2024201derived
Q2 FY2024150derived
Q1 FY2024206reported
Q4 FY2023172derived
Q3 FY2023238derived
Q2 FY2023251derived
Q1 FY2023263reported
Q4 FY2022157derived
Q3 FY2022244derived
Q2 FY2022255derived
Q1 FY2022269reported
Q4 FY2021146derived
Q3 FY2021237derived
Q2 FY2021244derived
Q1 FY2021249reported
Q4 FY2020194derived
Q3 FY2020198derived
Q2 FY2020199derived
Q1 FY2020203reported
Q4 FY2019197derived
Q3 FY2019193derived
Q2 FY2019193derived
Q1 FY2019189reported
Q4 FY2018190derived
Q3 FY2018201derived
Q2 FY2018188derived
Q1 FY2018195reported
Q4 FY2017190derived
Q3 FY2017190derived
Q2 FY2017191derived
Q1 FY2017189reported
Q4 FY2016184derived
Q3 FY2016184derived
Q2 FY2016168derived
Q1 FY2016161reported

CSV with all sources · Technical ID: dna

More metrics for Jabil

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$184M (derived)
Period
Q4 FY2016, ended Aug 31, 2016 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 697M − 513M = $184M (FY value from 10-K 0001193125-17-313834; 9-month value from the Q3-10-Q)
Source
10-K, filed Oct 19, 2017 · 0001193125-17-313834
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$184MOct 19, 201710-K 0001193125-17-313834derived · confidence 1. · current